参考文献/References:
[1] Vanden Bossche L,Vanderstraeten G.Heterotopic ossification:a review[J].J Rehabil Med,2005,37(3):129-136.
[2] Thomas BJ,Amstutz HC.Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty[J].J Bone Joint Surg Am,1985,67(3):400-403.
[3] Rosendahl S,Christoffersen JK,Norgaard M.Para-articular ossification following hip replacement.70 arthroplasties ad modum Moore using McFarland's approach[J].Acta Orthop Scand,1977,48(4):400-444.
[4] Ahrengart L.Periarticular heterotopic ossification after total hip arthroplasty.Risk factors and consequences[J].Clin Orthop Relat Res,1991,(263):49-58.
[5] Gear AJ,Buckley C,Kaplan F,et al.Multifactorial refractory heterotopic ossification[J].Ann Plast Surg,2004,52(3):319-324.
[6] Urist MR,Nakagawa M,Nakata N,et al.Experimental myositis ossificans:cartilage and bone formation in muscle in response to a diffusible bone matrix-derived morphogen[J].Arch Pathol Lab Med,1978,102(6):312-316.
[7] 孙伟方,王晔恺,刘晓光,等.血清骨形成蛋白-4水平与异位骨化的关系研究[J].中医正骨,2012,24(6):37-41.
[8] Eggli S,Woo A.Risk factors for heterotopic ossification in total hip arthroplasty[J].Arch Orthop Trauma Surg,2001,121(9):531-535.
[9] 吴立东,吴锋锋,叶凯山,等.初次全髋关节置换术后异位骨化[J].中华骨科杂志,2007,27(12):910-914.
[10] Ahrengart L,Lindgren U.Heterotopic bone after hip arthroplasty.Defining the patient at risk[J].Clin Orthop Relat Res,1993,(293):153-159.
[11] 赵廷宝,范清宇,唐农轩,等.异位骨化致全髋关节置换术后髋关节功能障碍的防治研究[J].现代康复,2001,5(3):25-26.
[12] 沈清龙,邢更彦.人工全髋关节置换术后异位骨化[J].河北医药,1997,19(4):218-219.
相似文献/References:
[1]孙伟方,王晔恺,刘晓光,等.血清骨形成蛋白-4水平与异位骨化的关系研究[J].中医正骨,2012,24(06):37.
SUN Wei-fang*,WANG Ye-kai,LIU Xiao-guang,et al.Study on the relationship between serum bone morphogenetic protein-4 levels and heterotopic ossification[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(01):37.
[2]袁志峰.胸椎后纵韧带骨化的研究进展[J].中医正骨,2012,24(07):66.
[3]顾洪辉,万双林,俞捷,等.T-Saw棘突纵割式颈椎管扩大成形术治疗
颈椎后纵韧带骨化[J].中医正骨,2013,25(04):63.